Senseion Therapeutics, Inc.
First-in-class therapeutics for chloride ion-channel diseases
SAINT LOUIS, United States · Founded 2020 · $2.0M raised
- Headquarters
- SAINT LOUIS, Missouri
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- senseion.com
- Total Funding
- $2.0M
- Last Round
- $2.0M GrantSep 2019
- Rounds
- 2
About
Senseion Therapeutics is a clinical-stage biopharmaceutical company translating foundational IP from the Sah laboratory into therapeutics for chloride ion-channel diseases. Its lead drug candidate, SN-40X, targets diabetes and its cardiovascular complications as a first-in-class treatment. The company is funded through SBIR grants from the Department of Health and Human Services.
Summary
Senseion Therapeutics, Inc. is a Biotech company based in SAINT LOUIS, United States, founded in 2020. It has raised $2.0M in total across 2 rounds, most recently a $2.0M Grant round in Sep 2019. Investors include HHS/NHLBI SBIR.
Funding History
Sep 2019
Sign up to see all 2 rounds
Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/senseion-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/senseion-therapeutics-inc" alt="Senseion Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>